Zilia
Quebec
About Zilia
Zilia has developed a non-invasive platform technology that uses imaging, spectrometry and artificial intelligence to quantitatively measure different biomarkers in the human eye. Zilia’s initial product, Zilia Ocular, is the first retinal camera to quantify oxygen saturation, a crucial biomarker in ocular diseases such as glaucoma, DR and AMD. Zilia aims to revolutionize the prevention, diagnosis and management of these diseases by generating actionable data about the eye’s metabolic activity.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.2M
- Funding stage: Seed
- Last round: Convertible Note (May 2025)
- Website: ziliahealth.com
- Phone: 1-833-501-6996
Industries & Categories
Artificial Intelligence (AI), Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/zilia-113641 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.